LINKS
Peer Review and Quality Control

Peer Review Is an Effective Screening Process to Evaluate Medical Manuscripts

(JAMA. 1994;272:105-107)

Margaret Abby; Michael D. Massey, MCM; Susan Galandiuk, MD; Hiram C. Polk, Jr, MD

Objective.--To measure the effectiveness of peer review as a screening process to evaluate medical manuscripts.

Design.--Retrospective.

Setting.--The editorial office of the American Journal of Surgery (AJS ).

Method.--A MEDLINE search was conducted of publications from 1984 to 1992 for manuscripts that were identical or similar to those rejected by AJS between January and December 1989. Manuscripts that were submitted to AJS by foreign authors were excluded because of the presumed difficulty in tracking foreign-language publications.

Main Outcome Measures.--The percentage of manuscripts rejected by AJS that were subsequently published in journals indexed by MEDLINE, the time from rejection to ultimate publication, and the journal of publication. The reasons for rejection were also documented. We assumed that the majority of rejected manuscripts would be published within 3 years after rejection.

Results.--One hundred twenty-five manuscripts submitted by North American authors were rejected by AJS in 1989, and 62% were not subsequently published in another core medical journal during the study period. The average duration between rejection and later publication was 17 months. Of those manuscripts subsequently published, 54% appeared in general surgical journals, including 12% that were revised, reevaluated, and later accepted by AJS. Twenty-nine percent of the rejected manuscripts were published in specialty medical journals, 10% in state and local journals, and the remainder in general medical journals. Twenty-eight percent of the authors of rejected manuscripts had previously and subsequently published manuscripts on very similar subjects.

Conclusions.--Our data indicate that the review process serves as a sieve and influences whether manuscripts are published in core medical journals. This was demonstrated by the fact that rejected manuscripts often were not published in other indexed medical journals.

(JAMA. 1994;272:105-107)


Little sound scientific research has been published on the effectiveness of the review process.[1] Skeptics of the process believe that peer review exercises little control over what is published. Some even speculate that persistent authors forward their manuscripts from journal to journal in a random fashion until eventual publication. Our study was designed to measure the effectiveness of the peer review process by determining what percentage of manuscripts rejected by the American Journal of Surgery (AJS) were ultimately published or eliminated from the core medical literature. We also reviewed the frequency with which an author had published manuscripts on very similar subjects to the one rejected by AJS.

METHODS

We retrospectively studied the bibliographic fate and frequency of similar publications of all freestanding manuscripts that were submitted to AJS by North American authors but were rejected by AJS between January and December 1989. A freestanding manuscript was one that had not been submitted to AJS through one of the journal-affiliated societies. Relevant data regarding rejected manuscripts were extracted from editorial office records. Foreign manuscripts were excluded from the study because of the presumed difficulty in tracking overseas manuscripts and non-English-language publications.

The AJS is published monthly by Reed Elsevier Medical Publishers, Belle Meade, NJ, with Hiram C. Polk, Jr, MD, University of Louisville (Ky), serving as editor in chief. The AJS publishes about 1226 pages of original articles per year and has approximately 17,000 subscribers.

To determine the outcome of each rejected manuscript, the scope of the data collection process was defined beforehand.[2] Pertinent information regarding only those manuscripts rejected during the year 1989 was retrieved from the AJS tracking files. These files contained the letter of rejection and the reviewer critiques for each manuscript. The main database of the National Library of Medicine (MEDLINE) on CD-ROM (SilverPlatter Information Retrieval System Version 3.1 [SPIRS 3.11], SilverPlatter Information Inc, Norwood, Mass) was searched for a listing of the principal author's publications from 1989 to 1992. MEDLINE is automated to retrieve all publications of the principal author, regardless of whether that author is the primary author. Manuscripts in which the principal author was subsequently deleted may have been missed by this process.

A finding from the search was only defined as a "subsequent publication" when (1) it contained a title as well as a list of authors identical to those of the rejected manuscript or (2) there was a slight variation in the authorship but the MEDLINE abstract contained results and conclusions identical to those discussed in the reviewer critiques. The rejected manuscript could not be compared with the subsequently published manuscript because of the journal policy of returning all rejected manuscripts and artwork to the corresponding author with the letter of rejection. A comparison of the MEDLINE abstract with data from the tracking file resolved questions regarding the identity of the rejected manuscript with the one found in the search.

The type of journal in which the manuscript was ultimately published was recorded, as were the circulation numbers for each journal and the Science Citation Index rankings for the journals that published the highest number of rejected AJS manuscripts.[3] [4] Data were then entered into a computerized database (Paradox 3.0, Borland International, Scotts Valley, Calif) for further assessment of the results. The delay to publication was calculated by the computer as the interval between the date of rejection and the month and year of subsequent publication.

As an additional assessment to determine how effective the review process was in screening orginality, we determined the highest occurrence of similar publications, ie, whether an author had published similar subjects previously and subsequently to the one rejected by AJS. The data were analyzed in the same fashion as were "subsequent publications" but also arbitrarily included data 5 years before AJS submission as well as 3 years after AJS rejection (1984 to 1992). Briefly, we carefully reviewed the authors and titles of the MEDLINE search results manually and/or with the computer for any publication that appeared to report a similar subject as the one rejected by AJS. We were unable to compare the actual publications line by line, except for one case with nearly identical titles. A publication was only defined as "similar" when the author appeared to publish the same or nearly identical information (Bruce Squires, MD, PhD. CBE Views. 1993;16:98). The AJS editorial office did not retain copies of the manuscripts after rejection, so no comparison of manuscripts with those subsequently published was possible other than for the title and authors. Nearly identical titles and authors were presumed to represent similar manuscripts.

To determine the reasons that each manuscript was deemed unacceptable for publication in AJS, each rejection letter was reviewed. All AJS reviewer critiques were summarized in the letter of rejection from the editor. The AJS has access to a 58-member editorial advisory board and nearly 200 ad hoc reviewers. Each negative comment made by the reviewer or editor was defined as a reason for rejection and was categorized as shown in the Table. A rejection by AJS implied that the quality of the manuscript was lower than that of accepted manuscripts, except for case reports, which were rejected by AJS because of journal policy. We assumed that a proportion of the manuscripts rejected by AJS in 1989 could have also been rejected elsewhere. However, the previous submission data were not available from authors or other publishers. Each rejected AJS manuscript, except for case reports, underwent peer review evaluation by three to five reviewers. The review process was defined as any assessment of manuscript quality by an assigned reviewer or the journal editor. The AJS reviewers were aware of the identity of contributing authors, but contributing authors were not aware of the identity of AJS reviewers.

RESULTS

A total of 347 freestanding manuscripts were submitted to AJS in 1989, of which only 99 (29%) were accepted and 248 (71%) were rejected. Of those rejected, 125 were classified as free-standing manuscripts submitted by North American authors, and 77 (62%) of those 125 were not published by a core medical journal within 3 years following rejection by AJS. Only 48 (38%) of the rejected manuscripts submitted by North American authors were subsequently published. Twenty-eight (58%) of the 48 were published within 1 year of rejection, 15 (31%) within 2 years of rejection, and five (5%) within 3 years of rejection. The mean delay to subsequent publication was 17 months (range, 6 to 37 months). Approximately half (52%) of the published manuscripts appeared in print with identical manuscript titles; the remaining titles had changed. The sequence of authors had changed in 12 (25%) of the manuscripts. The subject matter of the rejected manuscript (eg, clinical or basic research reports) did not influence the rate of subsequent publication, except in the case of case reports. Twenty-one of the rejected manuscripts were case reports, and more than half were published elsewhere. Thirty-eight percent (27/72) of rejected clinical reports and 31% (10/32) of the remaining rejected manuscripts (eg, experimental reports, operative techniques) were published elsewhere.

The 48 subsequently published manuscripts appeared in 28 different medical journals. More than half (52%) of the 48 manuscripts were subsequently published in journals with a lower circulation than AJS.[3] The journal circulation rates for another eight manuscripts were unavailable. Six manuscripts (13%) were extensively revised, reevaluated, and later accepted by AJS. As stated previously, we also determined the Science Citation Index journal rankings for the journals that published the highest number of rejected AJS manuscripts. Eight (16%) of the 48 manuscripts were published by a single general surgical journal that had a much lower journal ranking than AJS (2286th vs 946th).[4] Another 10 rejected manuscripts appeared in journals that were not ranked. When categorized according to the type of journal, 26 (54%) of the subsequently published manuscripts appeared in general surgical journals, 14 (29%) appeared in specialty journals, five (10%) appeared in state and local journals, and the remainder appeared in general medical journals. Publication of manuscripts by surgical journals was associated with an additional 7-month mean delay to publication compared with manuscripts published by state and local journals (Figure).

Thirty-five (28%) of the 125 authors of rejected manuscripts had published articles very similar to the one rejected by AJS in 1989. Based on a percentage of the total number of articles on similar subjects, 48% were published before 1989 and 52% were published during and after 1989. Six authors in particular had a total of 139 similar publications during the 8-year period examined. The rejected manuscripts of the three authors with the highest number of similar publications were not subsequently published. One of these three authors had 83 publications in the literature that expressed the same theme 83 different ways. In three of the 83 publications, the titles were so similar to the manuscript rejected by AJS that only one word in the 18-word title was different, and four of the six original authors were the same as for the rejected manuscript. These three published articles were compared word for word. Although the abstract, introduction, and discussion sections of each manuscript varied slightly, the methods, results, tables, and figures were virtually identical. There was also no reference to the similar works.

COMMENT

Peer review is an effective screening process to evaluate medical manuscripts. This was demonstrated by the fact that the larger percentage (62%) of manuscripts rejected by AJS remained unpublished in the core medical literature. This finding is unique in that it reflects more favorably on the review process than have prior studies.[5] [6]

Prior studies of well-known and very well-respected medical journals reported dramatically different rates. The Journal of Clinical Investigation[5] and the New England Journal of Medicine[6] both reported an 85% rate of subsequent publication, and the British Medical Journal[7] reported a 68% rate for manuscripts rejected in the 1970s. The American Journal of Roentgenology[8] conducted a similar MEDLINE search for manuscripts rejected in 1986 and reported a 64% subsequent publication rate. The differences between these reports and our report may be attributed to the fact that two of these studies[5,8] included manuscripts published within 4 to 6 years following rejection rather than the 3-year interval reported herein. We believe that the rate of subsequent publication of manuscripts rejected by AJS is not likely to increase dramatically 4 to 6 years following rejection, as there appeared to be a steady annual decline in the number of manuscripts published after initial rejection.

It is possible that we underestimated our subsequent publication rate because publication in journals not indexed by MEDLINE were excluded from our study. However, higher publication rates reported by other studies were similarly based on MEDLINE searches.[8] [9] According to the National Library of Medicine,[10] those journals that are included in Index Medicus or MEDLINE are considered "the highest quality and most important biomedical and health sciences journals published throughout the world." Because our goal was to measure the effectiveness of the review process, our report emphasized core medical journals with national exposure.

The prestige of the journal to which a biomedical manuscript is originally submitted may account for the different rates of subsequent publication between journals within the medical field. Our study showed that more than half of the ultimately published manuscripts appeared in journals with a lower journal circulation rate than AJS and that the journal with the highest accumulation of subsequent publications also has a much lower Science Citation Index journal ranking than does AJS. The hierarchy of journals in medicine lends itself to the hypothesis that many rejected manuscripts are submitted to the next-lower-level journal until acceptance.[11] In a recent report,[12] the New England Journal of Medicine had the lowest number of prior rejections of nine journals studied. Had we studied the previous rejection pattern of manuscripts prior to their being submitted to AJS, we may have found a high number of manuscripts that had been rejected by prestigious journals.[13]

The initial acceptance rates of journals of various disciplines are lower overall in the fields of human sciences (eg, medicine, psychology, sociology) than in physical sciences (eg, astronomy, physics, chemistry).[11] Differences between disciplines are more thoroughly discussed elsewhere.[14]

Another outcome that we attempted to measure was similar publication before and after AJS rejection. The fact that three of six authors with the highest number of similar publications did not find another journal willing to publish that rejected manuscript within 3 years of rejection suggests that the review process screened originality of published data somewhat but still permitted similar manuscripts to be published. A recent study of the British Medical Journal[15] reported that duplicate publication was increasing each year. One method to help prevent duplication is for editors to perform a MEDLINE search on each title and author tentatively accepted for publication. Many editors agree, however, that the expense of such a procedure would be prohibitive and time-consuming and that authors should be held accountable for the manuscripts they submit for publication.

When a manuscript is accepted for publication following the review process, it may not appear in the literature for several months. This delay from submission to publication may prevent important scientific research from reaching clinicians in a timely fashion and is partly due to the structure of the review process, which involves additional time for reviewers to assess manuscripts before publication. Geographically restricted journals (ie, state and local) generally do not have extensive review processes. This probably explains why the publication delay in our study was shorter for state and local journals.

We conclude that the review process serves as a sieve and influences whether manuscripts are published in core medical journals. The overall implication is that the review process effectively prevents many lower-quality or duplicate manuscripts from being published in the indexed medical literature.


From the Department of Surgery, University of Louisville (Ky) School of Medicine, and The American Journal of Surgery, Reed Elsevier Medical Publishers, USA, Belle Mead, NJ.

Presented at the Second International Congress on Peer Review in Biomedical Publication, Chicago, Ill, September 9, 1993.

Reprint requests to the Department of Surgery, University of Louisville, Louisville, KY 40292 (Dr Polk).


References

1. Bailar JC III, Patterson K. Journal peer review: the need for a research agenda. N Engl J Med. 1985;310:654-657.

2. Williamson JW, Goldschmidt PG, Colton T. The quality of medical literature: an analysis of validation assessments. In: Bailar JC III, Mosteller F, eds. Medical Uses of Statistics. Waltham, Mass: NEJM Books; 1986:370-391.

3. Ulrich's International Periodicals Directory 1992-1993. 31st ed. New York, NY: RR Bowker; 1993.

4. Garfield E. SCI Journal Citation Reports: A Bibliographic Analysis of Science Journals in the ISI Data Base. Philadelphia, Pa: Institute for Scientific Information; 1988;19.

5. Wilson JD. Peer review and publication: presidential address before the 70th Annual Meeting of the American Society for Clinical Investigation. J Clin Invest. 1978;58:1697-1701.

6. Relman AS. Are journals really quality filters? In: Goffman W, Bruer JT, Warren KS, eds. Coping With the Biomedical Literature Explosion: A Qualitative Approach. New York, NY: The Rockefeller Foundation; 1978:54-60.

7. Lock S. A Difficult Balance: Editorial Peer Review in Medicine. London, England: Nuffield Provincial Hospitals Trust; 1985.

8. Chew FS. Fate of manuscripts rejected for publication in the AJR. AJR Am J Roentgenol. 1991;156:627-632.

9. Yentis SM, Lerman J. Publication of abstracts presented at anaesthesia meetings. Can J Anaesth. 1993;40:632-634.

10. National Library of Medicine. List of Journals Indexed in Index Medicus 1993. Bethesda, Md: US Dept of Health and Human Services; 1993.

11. Abt HA. What happens to rejected astronomical papers? Publ Astronomical Soc Pacific. 1988;100:506-508.

12. Whitman N, Eyre S. The pattern of publishing previously rejected articles in selected journals. Fam Med. 1985;17:26-28.

13. Stossel TP. Beyond rejection: a user's view of peer review. In: Bailar JC III, Angell M, Boots S, eds. Ethics and Policy in Scientific Publication. Bethesda, Md: Council of Biology Editors; 1990:268-272.

14. Garvey WD, Lin N, Nelson CE. Communication in the physical and social sciences. In: Garvey WD, ed. Communication: The Essence of Science. Elmsford, NY: Pergamon Press Inc; 1979:280-299.

15. Waldron T. Is duplicate publishing on the increase? BMJ. 1992;304:1029.

Table of Contents